These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Inborn errors of metabolism associated with unusual odors. Carpenter DG; Carter CH J Fla Med Assoc; 1970 May; 57(5):31-3. PubMed ID: 5449191 [No Abstract] [Full Text] [Related]
24. The association between acute fatty liver of pregnancy and fatty acid oxidation disorders. Jamerson PA J Obstet Gynecol Neonatal Nurs; 2005; 34(1):87-92. PubMed ID: 15673650 [TBL] [Abstract][Full Text] [Related]
27. [Study of the inborn errors of mitochondrial fatty acid beta-oxidation deficiency]. Zhu JM; Yang Z Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):214-7. PubMed ID: 16617370 [TBL] [Abstract][Full Text] [Related]
28. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis. Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767 [TBL] [Abstract][Full Text] [Related]
29. Measurement of plasma very long-chain fatty acids as a preliminary screening procedure for the diagnosis of peroxisomal disorders. Steinberg SJ; Fensom AH; Dalton NR; Toseland PA; Kennedy CR; Mowat AP J Inherit Metab Dis; 1994; 17(3):323-6. PubMed ID: 7807943 [No Abstract] [Full Text] [Related]
31. Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation. Rinaldo P; Studinski AL; Matern D Prenat Diagn; 2001 Jan; 21(1):52-4. PubMed ID: 11180241 [No Abstract] [Full Text] [Related]
32. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders. Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002 [TBL] [Abstract][Full Text] [Related]
33. Implications of impaired ketogenesis in fatty acid oxidation disorders. Olpin SE Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):293-308. PubMed ID: 14769488 [TBL] [Abstract][Full Text] [Related]
34. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review. Vockley J; Marsden D; McCracken E; DeWard S; Barone A; Hsu K; Kakkis E Mol Genet Metab; 2015; 116(1-2):53-60. PubMed ID: 26116311 [TBL] [Abstract][Full Text] [Related]
35. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report. Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Gu XF J Inherit Metab Dis; 2007 Aug; 30(4):507-14. PubMed ID: 17347912 [TBL] [Abstract][Full Text] [Related]
36. [Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders]. Peña Quintana L; Sanjurjo Crespo P An Esp Pediatr; 2001 Dec; 55(6):524-34. PubMed ID: 11730586 [TBL] [Abstract][Full Text] [Related]
37. Fatty acid oxidation disorders: maternal health and neonatal outcomes. Rector RS; Ibdah JA Semin Fetal Neonatal Med; 2010 Jun; 15(3):122-8. PubMed ID: 19926542 [TBL] [Abstract][Full Text] [Related]